Hi folks. I was looking for the results of the Australian trial which I saw just the other day.
- Does anyone know why the Australian trial was so short given that it is known that it takes rvx-208 12 weeks (I recall) for the increases in ApoA-l to become evident? Perhaps they didn't have that information at the time they designed the trial? Cost?
- Does anyone one know what the 2 Chinese patents are? rvx-208 seems obvious, but is rvx-208 with rosuvastatin also one of the patents? If so it is very good news!!!
I'm sensing that Agoracom is moving up on my Google searches for RVX...good news.
GLTA
Cheers
Toinv
